David Allen Brenner MD
Vice Chancellor ofr Health Sciences and Dean, School of Medicine at UC San Diego
Join to View Full Profile
9300 Campus Point DrLa Jolla, CA 92037
Phone+1 858-657-8381
Fax+1 858-822-0084
Dr. Brenner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 1985 - 1988- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1985 - 1986
NIH Clinical CenterPost-Doctoral Fellowship, 1982 - 1985
Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
Yale School of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1985 - 2025
NY State Medical License 2003 - 2009
NC State Medical License 1993 - 2004
MD State Medical License 1982 - 1986
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Bomedical Scholar Pew Foundation, 1986
- Fellow (FACP) American College of Physicians, 2005
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
Publications & Presentations
PubMed
- 2 citationsClinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease.Luis Antonio Diaz, Sheldon Morris, Shravan Dave, Susy M Kim, Wathnita Sarik
Alimentary Pharmacology & Therapeutics. 2025-04-01 - Regulation of Hepatic Stellate Cell Phenotypes in MASH.Tatiana Kisseleva, Souradipta Ganguly, Rabi Murad, Allen Wang, David A Brenner
Gastroenterology. 2025-03-20 - 1 citationsAlternatives to animal testing to assess MASH drugs and hepatotoxicity.David A Brenner
Hepatology. 2025-01-01
Press Mentions
Role of Macrophages in Fatty Liver Disease OutcomesAugust 24th, 2024- Macrophage Mix Helps Determine Rate and Fate of Fatty Liver DiseaseAugust 22nd, 2024
- Macrophage Mix Helps Determine Rate and Fate of Fatty Liver DiseaseAugust 22nd, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
